The data shown below were collected from the profiles of 45 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Strategies to improve retention in randomised trials
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2013
|
| DOI | 10.1002/14651858.mr000032.pub2 |
| Pubmed ID | |
| Authors |
Valerie C Brueton, Jayne Tierney, Sally Stenning, Seeromanie Harding, Sarah Meredith, Irwin Nazareth, Greta Rait |
| Abstract |
Loss to follow-up from randomised trials can introduce bias and reduce study power, affecting the generalisability, validity and reliability of results. Many strategies are used to reduce loss to follow-up and improve retention but few have been formally evaluated. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 23 | 51% |
| Australia | 2 | 4% |
| Saudi Arabia | 1 | 2% |
| Germany | 1 | 2% |
| Hong Kong | 1 | 2% |
| Ireland | 1 | 2% |
| United States | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 14 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 40% |
| Scientists | 13 | 29% |
| Practitioners (doctors, other healthcare professionals) | 11 | 24% |
| Science communicators (journalists, bloggers, editors) | 3 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 419 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | <1% |
| Ireland | 1 | <1% |
| Mozambique | 1 | <1% |
| Egypt | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 412 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 84 | 20% |
| Researcher | 68 | 16% |
| Student > Ph. D. Student | 48 | 11% |
| Student > Bachelor | 42 | 10% |
| Student > Doctoral Student | 23 | 5% |
| Other | 65 | 16% |
| Unknown | 89 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 126 | 30% |
| Nursing and Health Professions | 66 | 16% |
| Psychology | 41 | 10% |
| Social Sciences | 27 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 3% |
| Other | 38 | 9% |
| Unknown | 110 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2020.
All research outputs
#987,578
of 26,544,284 outputs
Outputs from Cochrane database of systematic reviews
#1,784
of 13,265 outputs
Outputs of similar age
#9,864
of 324,515 outputs
Outputs of similar age from Cochrane database of systematic reviews
#33
of 228 outputs
Altmetric has tracked 26,544,284 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,265 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.